Prednisone Active Not Recruiting Phase 1 / 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01998971A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma